News >

SCLC Paradigm Advances With Immunotherapy, Integration of Rapid Research Autopsies

Caroline Seymour
Published: Monday, Mar 23, 2020

Hui-Zi Chen, MD, PhD, an assistant professor in the Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center-James

Hui-Zi Chen, MD, PhD

The use of immunotherapy has led to a paradigm shift in the treatment of patients with extensive-stage small cell lung cancer (ES-SCLC), but unmet needs remain, according to Hui-Zi Chen, MD, PhD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication